LONE TREE, Colo., Aug. 18, 2023 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, introduces its next generation Cochlear ™ Osia ® System with the ...
In the United States, the Osia System is now cleared for children ages 5 and older The Osia System, which launched commercially in 2020, is indicated for people with conductive hearing loss, mixed ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: Cochlear Limited is ...
In celebration of International Cochlear Implant Day, Cochlear North America is proud to announce the recipients of the 2026 Cochlear Academic Scholarships. This year, eight exceptional students, who ...
The U.S. FDA has cleared Cochlear Ltd.’s newest cochlear implant, the Osia 2 system, an active implantable bone conduction hearing system. Unlike Cochlear’s traditional implant, the Osia implant ...
Cochlear Limited, a healthcare leader in implantable hearing solutions since 1981, invests heavily in R&D, exceeding $180 million annually. Their innovative products, including the Cochlear Osia 2 ...
The new Osia ® System with Osia OSI300 Implant enables patients to undergo MRI at 3.0 Tesla (T) without the need for surgery This has been made possible by the OSI300's unique Piezo Power™ technology ...
LONE TREE, Colo., April 19, 2024 /PRNewswire/ -- - Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) clearance to lower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results